nodes	percent_of_prediction	percent_of_DWPC	metapath
Gliclazide—VEGFA—malignant glioma	0.722	1	CbGaD
Gliclazide—Leg edema—Temozolomide—malignant glioma	0.0039	0.0348	CcSEcCtD
Gliclazide—Sensory disturbance—Temozolomide—malignant glioma	0.00339	0.0303	CcSEcCtD
Gliclazide—Paresis—Temozolomide—malignant glioma	0.00288	0.0257	CcSEcCtD
Gliclazide—Disorder sight—Temozolomide—malignant glioma	0.00221	0.0197	CcSEcCtD
Gliclazide—Faecal incontinence—Carmustine—malignant glioma	0.00216	0.0192	CcSEcCtD
Gliclazide—Faecal incontinence—Temozolomide—malignant glioma	0.00208	0.0186	CcSEcCtD
Gliclazide—Cerebration impaired—Temozolomide—malignant glioma	0.00179	0.016	CcSEcCtD
Gliclazide—Haemorrhoids—Temozolomide—malignant glioma	0.00179	0.016	CcSEcCtD
Gliclazide—Aphasia—Carmustine—malignant glioma	0.00168	0.015	CcSEcCtD
Gliclazide—Tooth disorder—Temozolomide—malignant glioma	0.00162	0.0145	CcSEcCtD
Gliclazide—Aphasia—Temozolomide—malignant glioma	0.00162	0.0145	CcSEcCtD
Gliclazide—Digestion impaired—Temozolomide—malignant glioma	0.00157	0.014	CcSEcCtD
Gliclazide—Cholestasis—Temozolomide—malignant glioma	0.00138	0.0124	CcSEcCtD
Gliclazide—Otitis media—Temozolomide—malignant glioma	0.00135	0.012	CcSEcCtD
Gliclazide—Tolbutamide—CYP2C18—malignant glioma	0.00132	0.41	CrCbGaD
Gliclazide—Speech disorder—Carmustine—malignant glioma	0.00127	0.0113	CcSEcCtD
Gliclazide—Glipizide—PPARG—malignant glioma	0.00124	0.385	CrCbGaD
Gliclazide—Speech disorder—Temozolomide—malignant glioma	0.00122	0.0109	CcSEcCtD
Gliclazide—Disturbance in attention—Temozolomide—malignant glioma	0.00121	0.0108	CcSEcCtD
Gliclazide—Viral infection—Temozolomide—malignant glioma	0.00116	0.0104	CcSEcCtD
Gliclazide—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00111	0.00992	CcSEcCtD
Gliclazide—Hearing impaired—Temozolomide—malignant glioma	0.0011	0.00986	CcSEcCtD
Gliclazide—Vaginal inflammation—Temozolomide—malignant glioma	0.00105	0.00938	CcSEcCtD
Gliclazide—Neuropathy—Carmustine—malignant glioma	0.00102	0.00911	CcSEcCtD
Gliclazide—Coma—Carmustine—malignant glioma	0.000994	0.00887	CcSEcCtD
Gliclazide—Vaginal infection—Temozolomide—malignant glioma	0.000993	0.00886	CcSEcCtD
Gliclazide—Neuropathy—Temozolomide—malignant glioma	0.000987	0.00881	CcSEcCtD
Gliclazide—Neoplasm—Carmustine—malignant glioma	0.000984	0.00878	CcSEcCtD
Gliclazide—Neoplasm—Temozolomide—malignant glioma	0.000951	0.00848	CcSEcCtD
Gliclazide—Abnormal vision—Carmustine—malignant glioma	0.000949	0.00847	CcSEcCtD
Gliclazide—Mental disability—Carmustine—malignant glioma	0.000944	0.00842	CcSEcCtD
Gliclazide—Abnormal vision—Temozolomide—malignant glioma	0.000917	0.00818	CcSEcCtD
Gliclazide—Mental disability—Temozolomide—malignant glioma	0.000913	0.00814	CcSEcCtD
Gliclazide—Thrombophlebitis—Carmustine—malignant glioma	0.000913	0.00814	CcSEcCtD
Gliclazide—Thrombophlebitis—Temozolomide—malignant glioma	0.000882	0.00787	CcSEcCtD
Gliclazide—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.000878	0.00783	CcSEcCtD
Gliclazide—Gastroenteritis—Temozolomide—malignant glioma	0.000861	0.00768	CcSEcCtD
Gliclazide—Injury—Carmustine—malignant glioma	0.000859	0.00767	CcSEcCtD
Gliclazide—Deafness—Temozolomide—malignant glioma	0.000853	0.00761	CcSEcCtD
Gliclazide—Hepatic failure—Temozolomide—malignant glioma	0.000849	0.00758	CcSEcCtD
Gliclazide—Thirst—Temozolomide—malignant glioma	0.000802	0.00716	CcSEcCtD
Gliclazide—Hyponatraemia—Carmustine—malignant glioma	0.000793	0.00708	CcSEcCtD
Gliclazide—Diplopia—Carmustine—malignant glioma	0.00079	0.00705	CcSEcCtD
Gliclazide—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00079	0.00705	CcSEcCtD
Gliclazide—Diplopia—Temozolomide—malignant glioma	0.000763	0.00681	CcSEcCtD
Gliclazide—Dry skin—Temozolomide—malignant glioma	0.0007	0.00624	CcSEcCtD
Gliclazide—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.000687	0.00613	CcSEcCtD
Gliclazide—Abdominal distension—Temozolomide—malignant glioma	0.000664	0.00593	CcSEcCtD
Gliclazide—Chlorpropamide—PTGS1—malignant glioma	0.000662	0.205	CrCbGaD
Gliclazide—Pancytopenia—Carmustine—malignant glioma	0.000648	0.00578	CcSEcCtD
Gliclazide—Bronchitis—Temozolomide—malignant glioma	0.000635	0.00566	CcSEcCtD
Gliclazide—Pancytopenia—Temozolomide—malignant glioma	0.000627	0.00559	CcSEcCtD
Gliclazide—Hyperglycaemia—Carmustine—malignant glioma	0.000616	0.00549	CcSEcCtD
Gliclazide—Upper respiratory tract infection—Temozolomide—malignant glioma	0.000613	0.00547	CcSEcCtD
Gliclazide—Pneumonia—Carmustine—malignant glioma	0.000612	0.00546	CcSEcCtD
Gliclazide—Erectile dysfunction—Temozolomide—malignant glioma	0.000608	0.00542	CcSEcCtD
Gliclazide—Depression—Carmustine—malignant glioma	0.000607	0.00541	CcSEcCtD
Gliclazide—Photosensitivity reaction—Temozolomide—malignant glioma	0.000602	0.00537	CcSEcCtD
Gliclazide—Weight increased—Temozolomide—malignant glioma	0.0006	0.00536	CcSEcCtD
Gliclazide—Renal failure—Carmustine—malignant glioma	0.000598	0.00534	CcSEcCtD
Gliclazide—Neuropathy peripheral—Carmustine—malignant glioma	0.000597	0.00532	CcSEcCtD
Gliclazide—Hyperglycaemia—Temozolomide—malignant glioma	0.000595	0.00531	CcSEcCtD
Gliclazide—Urinary tract infection—Carmustine—malignant glioma	0.000592	0.00528	CcSEcCtD
Gliclazide—Pneumonia—Temozolomide—malignant glioma	0.000592	0.00528	CcSEcCtD
Gliclazide—Depression—Temozolomide—malignant glioma	0.000587	0.00523	CcSEcCtD
Gliclazide—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000583	0.0052	CcSEcCtD
Gliclazide—Neuropathy peripheral—Temozolomide—malignant glioma	0.000577	0.00514	CcSEcCtD
Gliclazide—Urinary tract infection—Temozolomide—malignant glioma	0.000572	0.0051	CcSEcCtD
Gliclazide—Hepatobiliary disease—Temozolomide—malignant glioma	0.000556	0.00496	CcSEcCtD
Gliclazide—Sinusitis—Temozolomide—malignant glioma	0.000552	0.00492	CcSEcCtD
Gliclazide—Hypoaesthesia—Carmustine—malignant glioma	0.000544	0.00485	CcSEcCtD
Gliclazide—Oedema peripheral—Carmustine—malignant glioma	0.000538	0.0048	CcSEcCtD
Gliclazide—Hepatitis—Temozolomide—malignant glioma	0.000528	0.00471	CcSEcCtD
Gliclazide—Visual impairment—Carmustine—malignant glioma	0.000527	0.0047	CcSEcCtD
Gliclazide—Hypoaesthesia—Temozolomide—malignant glioma	0.000525	0.00469	CcSEcCtD
Gliclazide—Pharyngitis—Temozolomide—malignant glioma	0.000524	0.00468	CcSEcCtD
Gliclazide—Oedema peripheral—Temozolomide—malignant glioma	0.00052	0.00464	CcSEcCtD
Gliclazide—Eye disorder—Carmustine—malignant glioma	0.000511	0.00456	CcSEcCtD
Gliclazide—Visual impairment—Temozolomide—malignant glioma	0.000509	0.00454	CcSEcCtD
Gliclazide—Flushing—Carmustine—malignant glioma	0.000507	0.00452	CcSEcCtD
Gliclazide—Erythema multiforme—Temozolomide—malignant glioma	0.000499	0.00445	CcSEcCtD
Gliclazide—Eye disorder—Temozolomide—malignant glioma	0.000494	0.0044	CcSEcCtD
Gliclazide—Tinnitus—Temozolomide—malignant glioma	0.000492	0.00439	CcSEcCtD
Gliclazide—Flushing—Temozolomide—malignant glioma	0.00049	0.00437	CcSEcCtD
Gliclazide—Arrhythmia—Carmustine—malignant glioma	0.000488	0.00435	CcSEcCtD
Gliclazide—Mental disorder—Carmustine—malignant glioma	0.000479	0.00427	CcSEcCtD
Gliclazide—Malnutrition—Carmustine—malignant glioma	0.000476	0.00424	CcSEcCtD
Gliclazide—Erythema—Carmustine—malignant glioma	0.000476	0.00424	CcSEcCtD
Gliclazide—Chills—Temozolomide—malignant glioma	0.000474	0.00423	CcSEcCtD
Gliclazide—Mental disorder—Temozolomide—malignant glioma	0.000463	0.00413	CcSEcCtD
Gliclazide—Back pain—Carmustine—malignant glioma	0.00046	0.0041	CcSEcCtD
Gliclazide—Erythema—Temozolomide—malignant glioma	0.00046	0.0041	CcSEcCtD
Gliclazide—Malnutrition—Temozolomide—malignant glioma	0.00046	0.0041	CcSEcCtD
Gliclazide—Tremor—Carmustine—malignant glioma	0.000446	0.00398	CcSEcCtD
Gliclazide—Back pain—Temozolomide—malignant glioma	0.000445	0.00397	CcSEcCtD
Gliclazide—Anaemia—Carmustine—malignant glioma	0.00044	0.00392	CcSEcCtD
Gliclazide—Agitation—Carmustine—malignant glioma	0.000437	0.0039	CcSEcCtD
Gliclazide—Tremor—Temozolomide—malignant glioma	0.000431	0.00384	CcSEcCtD
Gliclazide—Ill-defined disorder—Temozolomide—malignant glioma	0.000427	0.00381	CcSEcCtD
Gliclazide—Leukopenia—Carmustine—malignant glioma	0.000426	0.0038	CcSEcCtD
Gliclazide—Anaemia—Temozolomide—malignant glioma	0.000425	0.00379	CcSEcCtD
Gliclazide—Agitation—Temozolomide—malignant glioma	0.000422	0.00377	CcSEcCtD
Gliclazide—Angioedema—Temozolomide—malignant glioma	0.00042	0.00375	CcSEcCtD
Gliclazide—Malaise—Temozolomide—malignant glioma	0.000415	0.0037	CcSEcCtD
Gliclazide—Convulsion—Carmustine—malignant glioma	0.000412	0.00368	CcSEcCtD
Gliclazide—Leukopenia—Temozolomide—malignant glioma	0.000412	0.00367	CcSEcCtD
Gliclazide—Hypertension—Carmustine—malignant glioma	0.000411	0.00366	CcSEcCtD
Gliclazide—Palpitations—Temozolomide—malignant glioma	0.000406	0.00362	CcSEcCtD
Gliclazide—Chest pain—Carmustine—malignant glioma	0.000405	0.00361	CcSEcCtD
Gliclazide—Myalgia—Carmustine—malignant glioma	0.000405	0.00361	CcSEcCtD
Gliclazide—Anxiety—Carmustine—malignant glioma	0.000404	0.0036	CcSEcCtD
Gliclazide—Cough—Temozolomide—malignant glioma	0.000401	0.00358	CcSEcCtD
Gliclazide—Convulsion—Temozolomide—malignant glioma	0.000398	0.00355	CcSEcCtD
Gliclazide—Hypertension—Temozolomide—malignant glioma	0.000397	0.00354	CcSEcCtD
Gliclazide—Confusional state—Carmustine—malignant glioma	0.000391	0.00349	CcSEcCtD
Gliclazide—Myalgia—Temozolomide—malignant glioma	0.000391	0.00349	CcSEcCtD
Gliclazide—Arthralgia—Temozolomide—malignant glioma	0.000391	0.00349	CcSEcCtD
Gliclazide—Anxiety—Temozolomide—malignant glioma	0.00039	0.00348	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000389	0.00347	CcSEcCtD
Gliclazide—Discomfort—Temozolomide—malignant glioma	0.000387	0.00345	CcSEcCtD
Gliclazide—Infection—Carmustine—malignant glioma	0.000386	0.00344	CcSEcCtD
Gliclazide—Dry mouth—Temozolomide—malignant glioma	0.000383	0.00341	CcSEcCtD
Gliclazide—Thrombocytopenia—Carmustine—malignant glioma	0.00038	0.00339	CcSEcCtD
Gliclazide—Tachycardia—Carmustine—malignant glioma	0.000379	0.00338	CcSEcCtD
Gliclazide—Confusional state—Temozolomide—malignant glioma	0.000378	0.00337	CcSEcCtD
Gliclazide—Infection—Temozolomide—malignant glioma	0.000373	0.00333	CcSEcCtD
Gliclazide—Nervous system disorder—Temozolomide—malignant glioma	0.000368	0.00328	CcSEcCtD
Gliclazide—Thrombocytopenia—Temozolomide—malignant glioma	0.000367	0.00328	CcSEcCtD
Gliclazide—Skin disorder—Temozolomide—malignant glioma	0.000364	0.00325	CcSEcCtD
Gliclazide—Hypotension—Carmustine—malignant glioma	0.000363	0.00324	CcSEcCtD
Gliclazide—Hyperhidrosis—Temozolomide—malignant glioma	0.000363	0.00324	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000354	0.00316	CcSEcCtD
Gliclazide—Insomnia—Carmustine—malignant glioma	0.000351	0.00313	CcSEcCtD
Gliclazide—Paraesthesia—Carmustine—malignant glioma	0.000349	0.00311	CcSEcCtD
Gliclazide—Dyspnoea—Carmustine—malignant glioma	0.000346	0.00309	CcSEcCtD
Gliclazide—Somnolence—Carmustine—malignant glioma	0.000345	0.00308	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000342	0.00305	CcSEcCtD
Gliclazide—Insomnia—Temozolomide—malignant glioma	0.000339	0.00303	CcSEcCtD
Gliclazide—Paraesthesia—Temozolomide—malignant glioma	0.000337	0.00301	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Carmustine—malignant glioma	0.000335	0.00299	CcSEcCtD
Gliclazide—Dyspnoea—Temozolomide—malignant glioma	0.000335	0.00298	CcSEcCtD
Gliclazide—Somnolence—Temozolomide—malignant glioma	0.000334	0.00298	CcSEcCtD
Gliclazide—Constipation—Carmustine—malignant glioma	0.000332	0.00296	CcSEcCtD
Gliclazide—Pain—Carmustine—malignant glioma	0.000332	0.00296	CcSEcCtD
Gliclazide—Dyspepsia—Temozolomide—malignant glioma	0.00033	0.00295	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000324	0.00289	CcSEcCtD
Gliclazide—Fatigue—Temozolomide—malignant glioma	0.000323	0.00289	CcSEcCtD
Gliclazide—Pain—Temozolomide—malignant glioma	0.000321	0.00286	CcSEcCtD
Gliclazide—Constipation—Temozolomide—malignant glioma	0.000321	0.00286	CcSEcCtD
Gliclazide—Feeling abnormal—Carmustine—malignant glioma	0.00032	0.00285	CcSEcCtD
Gliclazide—Gastrointestinal pain—Carmustine—malignant glioma	0.000317	0.00283	CcSEcCtD
Gliclazide—Feeling abnormal—Temozolomide—malignant glioma	0.000309	0.00276	CcSEcCtD
Gliclazide—Abdominal pain—Carmustine—malignant glioma	0.000307	0.00274	CcSEcCtD
Gliclazide—Body temperature increased—Carmustine—malignant glioma	0.000307	0.00274	CcSEcCtD
Gliclazide—Gastrointestinal pain—Temozolomide—malignant glioma	0.000307	0.00274	CcSEcCtD
Gliclazide—Urticaria—Temozolomide—malignant glioma	0.000298	0.00266	CcSEcCtD
Gliclazide—Abdominal pain—Temozolomide—malignant glioma	0.000297	0.00265	CcSEcCtD
Gliclazide—Body temperature increased—Temozolomide—malignant glioma	0.000297	0.00265	CcSEcCtD
Gliclazide—Hypersensitivity—Carmustine—malignant glioma	0.000286	0.00255	CcSEcCtD
Gliclazide—Asthenia—Carmustine—malignant glioma	0.000279	0.00248	CcSEcCtD
Gliclazide—Hypersensitivity—Temozolomide—malignant glioma	0.000276	0.00247	CcSEcCtD
Gliclazide—Asthenia—Temozolomide—malignant glioma	0.000269	0.0024	CcSEcCtD
Gliclazide—Diarrhoea—Carmustine—malignant glioma	0.000266	0.00237	CcSEcCtD
Gliclazide—Pruritus—Temozolomide—malignant glioma	0.000265	0.00237	CcSEcCtD
Gliclazide—Dizziness—Carmustine—malignant glioma	0.000257	0.00229	CcSEcCtD
Gliclazide—Diarrhoea—Temozolomide—malignant glioma	0.000257	0.00229	CcSEcCtD
Gliclazide—Dizziness—Temozolomide—malignant glioma	0.000248	0.00221	CcSEcCtD
Gliclazide—Vomiting—Carmustine—malignant glioma	0.000247	0.0022	CcSEcCtD
Gliclazide—Rash—Carmustine—malignant glioma	0.000245	0.00218	CcSEcCtD
Gliclazide—Dermatitis—Carmustine—malignant glioma	0.000245	0.00218	CcSEcCtD
Gliclazide—Headache—Carmustine—malignant glioma	0.000243	0.00217	CcSEcCtD
Gliclazide—Vomiting—Temozolomide—malignant glioma	0.000239	0.00213	CcSEcCtD
Gliclazide—Rash—Temozolomide—malignant glioma	0.000237	0.00211	CcSEcCtD
Gliclazide—Dermatitis—Temozolomide—malignant glioma	0.000236	0.00211	CcSEcCtD
Gliclazide—Headache—Temozolomide—malignant glioma	0.000235	0.0021	CcSEcCtD
Gliclazide—Nausea—Carmustine—malignant glioma	0.000231	0.00206	CcSEcCtD
Gliclazide—Nausea—Temozolomide—malignant glioma	0.000223	0.00199	CcSEcCtD
Gliclazide—VEGFA—telencephalon—malignant glioma	0.000138	0.126	CbGeAlD
Gliclazide—ABCC8—brainstem—malignant glioma	0.000103	0.0935	CbGeAlD
Gliclazide—VEGFA—spinal cord—malignant glioma	9.68e-05	0.0882	CbGeAlD
Gliclazide—ABCC8—telencephalon—malignant glioma	9.1e-05	0.083	CbGeAlD
Gliclazide—VEGFA—cerebellum—malignant glioma	7.68e-05	0.07	CbGeAlD
Gliclazide—ABCC8—medulla oblongata—malignant glioma	7.15e-05	0.0652	CbGeAlD
Gliclazide—ABCC8—midbrain—malignant glioma	6.54e-05	0.0596	CbGeAlD
Gliclazide—ABCC8—spinal cord—malignant glioma	6.38e-05	0.0581	CbGeAlD
Gliclazide—VEGFA—brain—malignant glioma	6.24e-05	0.0568	CbGeAlD
Gliclazide—KCNJ11—central nervous system—malignant glioma	5.62e-05	0.0512	CbGeAlD
Gliclazide—KCNJ11—cerebellum—malignant glioma	5.49e-05	0.05	CbGeAlD
Gliclazide—ABCC8—central nervous system—malignant glioma	5.18e-05	0.0472	CbGeAlD
Gliclazide—ABCC8—cerebellum—malignant glioma	5.06e-05	0.0461	CbGeAlD
Gliclazide—KCNJ11—brain—malignant glioma	4.46e-05	0.0407	CbGeAlD
Gliclazide—ABCC8—brain—malignant glioma	4.11e-05	0.0374	CbGeAlD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	4.08e-05	0.000253	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—PDGFB—malignant glioma	4.07e-05	0.000252	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—BCHE—malignant glioma	4.07e-05	0.000252	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—ERBB2—malignant glioma	4.06e-05	0.000251	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—JAG2—malignant glioma	4.04e-05	0.00025	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—RAF1—malignant glioma	4.03e-05	0.000249	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—SLC5A5—malignant glioma	4.02e-05	0.000249	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	3.95e-05	0.000244	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—EGFR—malignant glioma	3.95e-05	0.000244	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—PIK3CB—malignant glioma	3.93e-05	0.000243	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—TP53—malignant glioma	3.9e-05	0.000242	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—RAF1—malignant glioma	3.82e-05	0.000236	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—AKT1—malignant glioma	3.8e-05	0.000235	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—TNF—malignant glioma	3.76e-05	0.000233	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—KRAS—malignant glioma	3.73e-05	0.000231	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	3.72e-05	0.00023	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—F2—malignant glioma	3.67e-05	0.000227	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—FN1—malignant glioma	3.67e-05	0.000227	CbGpPWpGaD
Gliclazide—ALB—Metabolism—COX8A—malignant glioma	3.66e-05	0.000226	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—IL2—malignant glioma	3.61e-05	0.000224	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	3.6e-05	0.000223	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—H3F3A—malignant glioma	3.55e-05	0.00022	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—PIK3CG—malignant glioma	3.51e-05	0.000217	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—MMP9—malignant glioma	3.49e-05	0.000216	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—EGF—malignant glioma	3.47e-05	0.000215	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—H3F3A—malignant glioma	3.41e-05	0.000211	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CXCR3—malignant glioma	3.38e-05	0.000209	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—GSTP1—malignant glioma	3.34e-05	0.000207	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—YWHAE—malignant glioma	3.29e-05	0.000204	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NTRK2—malignant glioma	3.29e-05	0.000204	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—COX8A—malignant glioma	3.28e-05	0.000203	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—FLT1—malignant glioma	3.28e-05	0.000203	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	3.27e-05	0.000202	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—DUSP6—malignant glioma	3.26e-05	0.000202	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—CAT—malignant glioma	3.25e-05	0.000201	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—GSTP1—malignant glioma	3.24e-05	0.0002	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—JAG1—malignant glioma	3.22e-05	0.000199	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—AKT2—malignant glioma	3.22e-05	0.000199	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NOTCH3—malignant glioma	3.21e-05	0.000198	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—FBXW7—malignant glioma	3.15e-05	0.000195	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—CAT—malignant glioma	3.15e-05	0.000195	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ASMT—malignant glioma	3.11e-05	0.000192	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—TFRC—malignant glioma	3.11e-05	0.000192	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—STAT3—malignant glioma	3.1e-05	0.000192	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—BDKRB2—malignant glioma	3.09e-05	0.000191	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—PIK3CD—malignant glioma	3.09e-05	0.000191	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—NCOR1—malignant glioma	3.07e-05	0.00019	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	3.04e-05	0.000188	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—COX8A—malignant glioma	2.99e-05	0.000185	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—NCOR1—malignant glioma	2.98e-05	0.000184	CbGpPWpGaD
Gliclazide—ALB—brain—malignant glioma	2.94e-05	0.0268	CbGeAlD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	2.93e-05	0.000181	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—KNG1—malignant glioma	2.93e-05	0.000181	CbGpPWpGaD
Gliclazide—ALB—Metabolism—BCAN—malignant glioma	2.92e-05	0.000181	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NOTCH2—malignant glioma	2.88e-05	0.000178	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—IFNA2—malignant glioma	2.87e-05	0.000178	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—SLC5A5—malignant glioma	2.85e-05	0.000177	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—EGFR—malignant glioma	2.82e-05	0.000174	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—KNG1—malignant glioma	2.81e-05	0.000174	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ASMT—malignant glioma	2.79e-05	0.000173	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—RAF1—malignant glioma	2.76e-05	0.000171	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	2.73e-05	0.000169	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—SOD1—malignant glioma	2.72e-05	0.000168	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—SLC6A3—malignant glioma	2.72e-05	0.000168	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—PIK3CB—malignant glioma	2.69e-05	0.000167	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—TNF—malignant glioma	2.68e-05	0.000166	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NTRK1—malignant glioma	2.68e-05	0.000166	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	2.67e-05	0.000165	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—KRAS—malignant glioma	2.66e-05	0.000165	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—BCAN—malignant glioma	2.62e-05	0.000162	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—KRAS—malignant glioma	2.61e-05	0.000161	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ASMT—malignant glioma	2.54e-05	0.000157	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—CAV1—malignant glioma	2.5e-05	0.000155	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—PTK2—malignant glioma	2.5e-05	0.000155	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—MMP3—malignant glioma	2.49e-05	0.000154	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	2.49e-05	0.000154	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—IL2—malignant glioma	2.47e-05	0.000153	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CDKN2B—malignant glioma	2.47e-05	0.000153	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—CAV1—malignant glioma	2.43e-05	0.00015	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PTK2—malignant glioma	2.4e-05	0.000148	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—PIK3CA—malignant glioma	2.4e-05	0.000148	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—BCAN—malignant glioma	2.39e-05	0.000148	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—HES1—malignant glioma	2.36e-05	0.000146	CbGpPWpGaD
Gliclazide—ALB—Metabolism—IDH2—malignant glioma	2.36e-05	0.000146	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NCOR1—malignant glioma	2.34e-05	0.000145	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—TP53—malignant glioma	2.32e-05	0.000144	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PIK3CG—malignant glioma	2.28e-05	0.000141	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PDGFRA—malignant glioma	2.24e-05	0.000139	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.22e-05	0.000137	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CYP2B6—malignant glioma	2.21e-05	0.000137	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PIK3CG—malignant glioma	2.21e-05	0.000137	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PPARG—malignant glioma	2.2e-05	0.000136	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—SPP1—malignant glioma	2.18e-05	0.000135	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PPARG—malignant glioma	2.13e-05	0.000132	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—IDH2—malignant glioma	2.11e-05	0.000131	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	2.1e-05	0.00013	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—PDGFB—malignant glioma	2.1e-05	0.00013	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TERT—malignant glioma	2.07e-05	0.000128	CbGpPWpGaD
Gliclazide—ALB—Metabolism—IDH1—malignant glioma	2.03e-05	0.000125	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PDGFB—malignant glioma	2.02e-05	0.000125	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—FGFR1—malignant glioma	2.01e-05	0.000124	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PIK3CD—malignant glioma	2e-05	0.000124	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—AKT1—malignant glioma	2e-05	0.000124	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.99e-05	0.000123	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—CAV1—malignant glioma	1.99e-05	0.000123	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CYP2B6—malignant glioma	1.99e-05	0.000123	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—HIF1A—malignant glioma	1.98e-05	0.000122	CbGpPWpGaD
Gliclazide—ALB—Metabolism—SPHK1—malignant glioma	1.96e-05	0.000121	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—AKT1—malignant glioma	1.96e-05	0.000121	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PIK3CD—malignant glioma	1.94e-05	0.00012	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—IDH2—malignant glioma	1.93e-05	0.000119	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CYP2C18—malignant glioma	1.92e-05	0.000119	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CAV1—malignant glioma	1.91e-05	0.000118	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—FN1—malignant glioma	1.89e-05	0.000117	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—F2—malignant glioma	1.89e-05	0.000117	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—KDR—malignant glioma	1.89e-05	0.000117	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—F2—malignant glioma	1.82e-05	0.000113	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—FN1—malignant glioma	1.82e-05	0.000113	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—IDH1—malignant glioma	1.82e-05	0.000113	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.82e-05	0.000112	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CYP2B6—malignant glioma	1.81e-05	0.000112	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—PIK3CG—malignant glioma	1.81e-05	0.000112	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.81e-05	0.000112	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—BAD—malignant glioma	1.8e-05	0.000111	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—EGF—malignant glioma	1.79e-05	0.000111	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—PTPN11—malignant glioma	1.78e-05	0.00011	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NOTCH1—malignant glioma	1.78e-05	0.00011	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—SPHK1—malignant glioma	1.76e-05	0.000109	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PIK3CB—malignant glioma	1.75e-05	0.000108	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CD80—malignant glioma	1.74e-05	0.000108	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PIK3CG—malignant glioma	1.74e-05	0.000108	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—APC—malignant glioma	1.74e-05	0.000108	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PTGS2—malignant glioma	1.73e-05	0.000107	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CYP2C18—malignant glioma	1.72e-05	0.000107	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—EGF—malignant glioma	1.72e-05	0.000106	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PTPN11—malignant glioma	1.71e-05	0.000106	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PIK3CB—malignant glioma	1.69e-05	0.000105	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PTGS2—malignant glioma	1.68e-05	0.000104	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—IDH1—malignant glioma	1.66e-05	0.000103	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—AKT2—malignant glioma	1.66e-05	0.000103	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.65e-05	0.000102	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	1.64e-05	0.000102	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—BRAF—malignant glioma	1.64e-05	0.000101	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.63e-05	0.000101	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—SPHK1—malignant glioma	1.6e-05	9.93e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—PIK3CD—malignant glioma	1.59e-05	9.85e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—AKT2—malignant glioma	1.59e-05	9.85e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.59e-05	9.85e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CYP2C18—malignant glioma	1.57e-05	9.73e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GSTT1—malignant glioma	1.55e-05	9.61e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PIK3CD—malignant glioma	1.53e-05	9.47e-05	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PTEN—malignant glioma	1.51e-05	9.33e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.48e-05	9.17e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.48e-05	9.16e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—FGF2—malignant glioma	1.46e-05	9.06e-05	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PTEN—malignant glioma	1.46e-05	9.05e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PTGS1—malignant glioma	1.46e-05	9e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.45e-05	8.97e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.43e-05	8.84e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—RAF1—malignant glioma	1.42e-05	8.8e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GSTT1—malignant glioma	1.39e-05	8.63e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—PIK3CB—malignant glioma	1.39e-05	8.59e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—MDM2—malignant glioma	1.37e-05	8.48e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—RAF1—malignant glioma	1.37e-05	8.45e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—BCHE—malignant glioma	1.35e-05	8.37e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—ERBB2—malignant glioma	1.35e-05	8.36e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.35e-05	8.35e-05	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—AKT1—malignant glioma	1.34e-05	8.3e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—SLC5A5—malignant glioma	1.34e-05	8.27e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PIK3CB—malignant glioma	1.33e-05	8.25e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PTGS1—malignant glioma	1.31e-05	8.08e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.3e-05	8.06e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.3e-05	8.05e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CXCL8—malignant glioma	1.28e-05	7.93e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—IL2—malignant glioma	1.27e-05	7.89e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GSTT1—malignant glioma	1.27e-05	7.87e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.26e-05	7.82e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.25e-05	7.75e-05	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	1.23e-05	7.62e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CASP3—malignant glioma	1.23e-05	7.59e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IL2—malignant glioma	1.22e-05	7.58e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—BCHE—malignant glioma	1.21e-05	7.51e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—SLC5A5—malignant glioma	1.2e-05	7.42e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PTGS1—malignant glioma	1.19e-05	7.37e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.19e-05	7.34e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—MMP9—malignant glioma	1.16e-05	7.17e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PTEN—malignant glioma	1.15e-05	7.13e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.13e-05	7.02e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.12e-05	6.96e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—BCHE—malignant glioma	1.11e-05	6.85e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—SLC5A5—malignant glioma	1.09e-05	6.77e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.09e-05	6.76e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—VEGFA—malignant glioma	1.08e-05	6.7e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GSTP1—malignant glioma	1.08e-05	6.66e-05	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PIK3CA—malignant glioma	1.06e-05	6.58e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CAT—malignant glioma	1.05e-05	6.48e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.03e-05	6.4e-05	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PIK3CA—malignant glioma	1.03e-05	6.38e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—STAT3—malignant glioma	1.03e-05	6.38e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.03e-05	6.34e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—NCOR1—malignant glioma	9.89e-06	6.12e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	9.8e-06	6.07e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GSTP1—malignant glioma	9.66e-06	5.98e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—MYC—malignant glioma	9.58e-06	5.93e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CAT—malignant glioma	9.4e-06	5.82e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—EGFR—malignant glioma	9.37e-06	5.8e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—KRAS—malignant glioma	9.21e-06	5.7e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	8.94e-06	5.53e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—NCOR1—malignant glioma	8.88e-06	5.49e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—KRAS—malignant glioma	8.85e-06	5.47e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GSTP1—malignant glioma	8.81e-06	5.45e-05	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—AKT1—malignant glioma	8.69e-06	5.38e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CAT—malignant glioma	8.57e-06	5.31e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—PIK3CA—malignant glioma	8.46e-06	5.24e-05	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—AKT1—malignant glioma	8.43e-06	5.22e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—TP53—malignant glioma	8.19e-06	5.07e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PIK3CA—malignant glioma	8.13e-06	5.03e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—NCOR1—malignant glioma	8.1e-06	5.01e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CAV1—malignant glioma	8.06e-06	4.99e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TP53—malignant glioma	7.86e-06	4.87e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.7e-06	4.77e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PIK3CG—malignant glioma	7.35e-06	4.54e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CAV1—malignant glioma	7.24e-06	4.48e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PPARG—malignant glioma	7.09e-06	4.39e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.92e-06	4.28e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—AKT1—malignant glioma	6.91e-06	4.28e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—AKT1—malignant glioma	6.64e-06	4.11e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CAV1—malignant glioma	6.6e-06	4.08e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PIK3CG—malignant glioma	6.59e-06	4.08e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PIK3CD—malignant glioma	6.46e-06	4e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PPARG—malignant glioma	6.36e-06	3.94e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.31e-06	3.9e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PIK3CG—malignant glioma	6.01e-06	3.72e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PPARG—malignant glioma	5.8e-06	3.59e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PIK3CD—malignant glioma	5.8e-06	3.59e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PIK3CB—malignant glioma	5.63e-06	3.48e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PTGS2—malignant glioma	5.58e-06	3.45e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PIK3CD—malignant glioma	5.29e-06	3.27e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PIK3CB—malignant glioma	5.05e-06	3.13e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PTGS2—malignant glioma	5.01e-06	3.1e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PTEN—malignant glioma	4.86e-06	3.01e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PIK3CB—malignant glioma	4.61e-06	2.85e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PTGS2—malignant glioma	4.57e-06	2.82e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PTEN—malignant glioma	4.37e-06	2.7e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PTEN—malignant glioma	3.98e-06	2.46e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PIK3CA—malignant glioma	3.43e-06	2.12e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PIK3CA—malignant glioma	3.08e-06	1.91e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PIK3CA—malignant glioma	2.81e-06	1.74e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—AKT1—malignant glioma	2.8e-06	1.73e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—AKT1—malignant glioma	2.52e-06	1.56e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—AKT1—malignant glioma	2.29e-06	1.42e-05	CbGpPWpGaD
